A nanoparticle-based wireless deep brain stimulation system that reverses Parkinson's disease

Area of Science:

• Neuroscience
• Biotechnology
• Materials Science

Background:

• Deep brain stimulation (DBS) offers precise neural modulation but necessitates invasive permanent implants.
• Parkinson's disease (PD) is characterized by the degeneration of dopamine neurons and the accumulation of α-synuclein aggregates.
• Current treatments for PD often manage symptoms but do not address the underlying pathology.

Purpose of the Study:

• To develop a novel wireless photothermal nanosystem for deep brain stimulation (DBS) to treat Parkinson's disease.
• To investigate the system's ability to eliminate α-synuclein aggregates and restore dopamine neuron function in the substantia nigra.
• To establish a minimally invasive therapeutic approach for neurodegenerative disorders.

Main Methods:

• A nanosystem (ATB NPs) was engineered, comprising gold nanoshells, an antibody for TRPV1 receptors, and β-synuclein peptides linked to a near-infrared (NIR) responsive element.
• ATB NPs were delivered stereotactically to target dopamine neurons in the substantia nigra, which express TRPV1 receptors.
• Pulsed NIR irradiation triggered ATB NPs to generate heat, activating TRPV1 receptors and inducing neuronal depolarization and action potentials.

Main Results:

• The photothermal activation of ATB NPs successfully induced calcium ion influx and neuronal firing in targeted dopamine neurons.
• Released β-synuclein peptides, in conjunction with heat shock protein (HSC70)-mediated autophagy, effectively degraded α-synuclein fibrils within neurons.
• The treatment restored the function of pathologically altered dopamine neurons and improved locomotor behaviors in a PD model.

Conclusions:

• The developed photothermal wireless DBS nanosystem demonstrates efficacy in clearing α-synuclein aggregates and rejuvenating dopamine neurons.
• This technology presents a promising, minimally invasive strategy for treating Parkinson's disease by addressing its core pathological mechanisms.
• The study highlights the potential of targeted photothermal stimulation combined with autophagy induction for neurodegenerative disease therapeutics.